Tenax Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +385.7% | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | -513.4% | – | -81.5% | -36.4% | +7,935.7% | +268.2% | +11.3% | +22.0% | -355.7% | – | +17.3% | – | |
| – | – | -174.5% | – | +66.1% | +107.8% | -139.6% | – | -18.0% | -359.5% | – | -90.9% | – | |
| – | +39,950.0% | -100.0% | – | +100.0% | +50.0% | -100.0% | – | – | – | – | – | – | |
| – | +4,932.6% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -100.0% | -100.0% | – | – | – | – | – | – | |
| – | +1.9% | – | -101.7% | – | -99.9% | +34,940.5% | -98.8% | +1,001.4% | +279.2% | +162.7% | -56.2% | – | |
| – | – | – | -214.8% | – | -103.9% | – | -136.1% | – | – | – | -103.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.